San Bruno, CA, United States of America

Benjamin Margolis

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Oregon Biomedical Engineering Institute. Active years: 2014-2017.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Benjamin Margolis

Introduction

Benjamin Margolis is an accomplished inventor based in San Bruno, CA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of hemorrhage control devices. With a total of 2 patents, Margolis continues to push the boundaries of innovation in medical technology.

Latest Patents

Margolis's latest patents focus on hemorrhage control devices and methods. These embodiments comprise a hemostatic composition that includes a plurality of liquid expandable articles capable of expanding upon contact with a liquid. A suitable composition consists of these liquid-expandable articles that can be mechanically uncoupled from one another, allowing them to move independently. The articles are made from a compressed material that can achieve a high degree of expansion upon liquid contact, enhancing their effectiveness in medical applications.

Career Highlights

Margolis is affiliated with the Oregon Biomedical Engineering Institute, where he applies his expertise to develop innovative solutions for medical challenges. His work has been instrumental in advancing techniques for controlling hemorrhage, which is critical in emergency medicine and surgical procedures.

Collaborations

Throughout his career, Margolis has collaborated with notable colleagues, including Kenton W Gregory and Lauryn L Baranowski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies.

Conclusion

Benjamin Margolis exemplifies the spirit of innovation in the biomedical field. His contributions to hemorrhage control devices demonstrate his commitment to improving medical outcomes and advancing technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…